APIs for research and impurities

(S)-Aspartimide is a drug product that is used in the synthesis of pharmaceuticals. Its purity should be greater than 99% and it should be free from detectable impurities. (S)-Aspartimide is metabolized by esterases, glutathione reductase, cytochrome P450 enzymes, and conjugation with glucuronic acid. It has been shown to inhibit the growth of bacteria that are resistant to penicillin, ampicillin, erythromycin, and gatifloxacin. (S)-Aspartimide has been found to have an anti-inflammatory effect due to its inhibition of prostaglandin synthesis.

4-Carboxy-3-ethoxy)phenyl acetic acid (CPAE) is a fluorescent compound that has been shown to have antidiabetic and luminescence properties. It absorbs light at wavelengths of 340, 405, and 455 nm and emits light at 525 nm. It also absorbs UV light at 310 nm and emits fluorescence at 495 nm. CPAE is formed by the condensation of two molecules of 4-carboxybenzaldehyde with one molecule of ethyl 3-ethoxypropanoate in the presence of a base. The crystals are monoclinic, with space group P2/c and lattice constants a = 12.872(1) Å, b = 7.319(1) Å, c = 17.814(2) Å, β = 98.664(9)°, Z = 2. The molecular weight is 182.24 g/mol and its molecular

Please enquire for more information about 17-Acetoxy-6-chloro-3-ethoxypregna-3,5-dien-20-one including the price, delivery time and more detailed product information at the technical inquiry form on this page

1-(5-(4-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (5FPP) is a drug product. It is an impurity standard for HPLC and analytical methods, as well as an API impurity. 5FPP is a synthetic compound that has been studied in metabolism studies. The metabolite of 5FPP is 1-(5-(4-fluorophenyl)-1H-pyrrolo[3,2,1-jk]thiazol-2(3H)-one).

2-(Naphthalen-2-ylmethyl)-4,5-dihydro-1H-imidazole is a medicinal compound that has shown promising results in cancer research. It works as an inhibitor of cyclin-dependent kinases, which are essential for cancer cell proliferation. This compound induces apoptosis in cancer cells by inhibiting the activity of certain proteins involved in tumor growth. Studies have shown that 2-(Naphthalen-2-ylmethyl)-4,5-dihydro-1H-imidazole analogs have potent anticancer activity and can inhibit the growth of human cancer cells. This compound has also been found to be present in urine samples from Chinese patients with cancer. Further research on this compound may lead to the development of new and effective treatments for various types of cancers.

L-Pyroglutamic acid-13C5 is a drug product that is used as an impurity standard in the synthesis of L-pyroglutamic acid, which is an API for the treatment of various diseases. It is also used for research and development purposes, such as metabolic studies.

MK-0249 is a potent inhibitor of hyaluronan-mediated tumor cell proliferation and migration. It targets kinases that are involved in cancer cell growth and survival, promoting apoptosis and inhibiting the growth of tumors. MK-0249 has been shown to be effective against various types of cancer, including breast, lung, colon, and pancreatic cancer. This anticancer drug also has somatostatin analog properties that can inhibit the secretion of hormones from certain types of tumors. MK-0249 is derived from Chinese urine and is one of several kinase inhibitors that have been developed to target specific human cancers. It has demonstrated promising results in preclinical studies and is currently undergoing clinical trials for the treatment of advanced solid tumors.

Hydrochlorothiazide is a sulfonamide that inhibits the activity of the enzyme, angiotensin-converting enzyme (ACE), which is responsible for converting angiotensin I to the potent vasoconstrictor, angiotensin II. It also has antihypertensive effects by blocking the production of aldosterone, which causes sodium retention and leads to high blood pressure. It is a byproduct in reactions with substances such as valsartan. Hydrochlorothiazide may react chemically with other medicines such as ampicillin and cefaclor.

Simotinib is a kinase inhibitor that has shown promising results in the treatment of various types of cancer. It targets specific proteins that are involved in the growth and survival of tumor cells, leading to apoptosis (cell death) and inhibition of cancer cell proliferation. This medicinal compound is an analog of cyclin-dependent kinases inhibitors and has been extensively studied in Chinese patients with lung cancer. Simotinib works by blocking the activity of certain enzymes that promote tumor growth, making it an effective anticancer agent. It has also been found to have potential therapeutic applications in other types of cancer, including breast and prostate cancer. Overall, Simotinib shows great promise as a targeted therapy for cancer treatment.